Consolidated figures · ₹ crore
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 271 | 321 | 334 | 301 | 268 | 274 | 349 | 440 | 462 | 201 | 250 | |
| COGS | 181 | 188 | 209 | 168 | 142 | 143 | 204 | 255 | 244 | 116 | 148 |
| Gross profit | 90 | 133 | 125 | 134 | 126 | 131 | 146 | 185 | 218 | 85 | 102 |
| 79 | 116 | 103 | 108 | 116 | 113 | 128 | 151 | 169 | 72 | 84 | |
| 11 | 17 | 23 | 26 | 10 | 18 | 18 | 35 | 49 | 14 | 18 | |
| OPM % | 4.2% | 5.3% | 6.8% | 8.5% | 3.7% | 6.6% | 5% | 7.9% | 10.7% | 6.8% | 7.2% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 6 | 3 | 4 |
| Interest | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| 189 | 18 | 11 | 4 | 3 | 15 | 8 | 5 | 17 | 9 | 1 | |
| Profit before tax | — | — | 28 | 24 | 8 | 29 | 21 | 34 | 60 | 19 | 16 |
| Tax | 38 | 7 | 4 | 5 | 5 | 8 | 7 | 9 | 16 | 2 | 3 |
| Tax % | — | — | 15.6% | 18.7% | 61% | 28.5% | 31.9% | 26.4% | 26% | 9.8% | 16.9% |
| 157 | 4 | 24 | 20 | 3 | 20 | 14 | 25 | 44 | 18 | 13 | |
| PAT margin % | 57.7% | 1.1% | 7.1% | 6.6% | 1.2% | 7.4% | 4% | 5.6% | 9.6% | 8.7% | 5.2% |
| EPS (₹) | — | — | — | — | 1.4 | 15.1 | 10.4 | 18.4 | 33 | 13.1 | 9.6 |
| EPS adjusted (₹) | 116.8 | 14.4 | 16.4 | 12.9 | 1.4 | 15.1 | 10.4 | 18.4 | 33 | 13.1 | 9.6 |
| — | — | — | — | 143.9% | 14.9% | 48.3% | 16.3% | 10.6% | 13.4% | 20.9% | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 200 | 202 | 242 | 255 | — | 286 | 297 | 315 | 355 | 149 | 160 |
| Minority interest | — | — | 2 | 4 | — | 1 | 1 | 1 | 1 | 0 | — |
| 11 | 11 | 9 | 7 | — | 2 | 2 | 7 | 7 | 3 | 4 | |
| 72 | 79 | 66 | 50 | — | 58 | 54 | 71 | 78 | 43 | 48 | |
| Total equity & liabilities | 289 | 298 | 325 | 322 | — | 354 | 361 | 402 | 447 | 202 | 219 |
| 47 | 47 | 108 | 109 | 124 | 122 | 121 | 116 | 122 | 34 | 41 | |
| CWIP | 2 | 2 | 1 | 2 | — | 0 | 1 | 12 | 13 | 8 | 2 |
| Investments | 65 | 92 | 76 | 58 | — | 73 | 75 | 65 | 92 | 78 | 70 |
| 175 | 157 | 140 | 153 | — | 159 | 164 | 208 | 219 | 83 | 107 | |
| Total assets | 289 | 298 | 325 | 322 | — | 354 | 361 | 402 | 447 | 202 | 219 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| -27 | 5 | -12 | -12 | 25 | -0 | 2 | 28 | 19 | 15 | |
| 52 | -0 | 19 | 14 | -11 | -2 | 0 | -22 | -8 | -10 | |
| -24 | -3 | -4 | -6 | -2 | -4 | -2 | -5 | -9 | -1 | |
| Net cash flow | 1 | — | — | — | 12 | -6 | 0 | 1 | 2 | 3 |
| Free cash flow | -24 | — | — | — | 21 | -4 | -12 | 16 | 15 | -6 |
| CFO / Operating profit % | -236.8% | 28.9% | -54.5% | -47.9% | 137.6% | -0.1% | 6.3% | 56.1% | 143.3% | 81.8% |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Speciality Chemical | 207.93 | 8.72 | 202.21 | 41.92 | 160.29 | 5.44 |
| Animal health | 42.15 | 5.45 | 17.21 | 10.56 | 6.65 | 81.95 |
₹ crore by fiscal year